Proton Pump Inhibitors (PPIs)

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/44

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

45 Terms

1
New cards

The Proton Pump

  • the final step in gastric acid secretion in the parietal cell is ______ ______ ______.

  • carried out by an enzyme ____/____-______ or the “proton pump” —> catalyzes the exchange of _______ ions for ______ ions in the stomach.

  • exchange is stimulated by ______ messengers (Ca2+ and cAMP) from ______ activation (histamine, gastrin, acetylcholine)

  • inhibitors of the pump will block both ______ and ______ secretion

  • extrusion of protons

  • H+/K+-ATPase, hydrogen, potassium

  • secondary, GPCR

  • basal, stimulated

2
New cards
<p>What does this structure represent?</p>

What does this structure represent?

the backbone for PPIs

3
New cards

The final step in gastric acid secretion in parietal cells is mediated by:

H⁺/K⁺-ATPase

4
New cards

The proton pump exchanges which ions across the parietal cell membrane?

Na⁺ out / K⁺ in

5
New cards

Which messenger pathways stimulate activation of the proton pump?

Ca²⁺ and cAMP

6
New cards

Which signaling molecules stimulate gastric acid secretion via GPCRs?

Histamine, gastrin, acetylcholine

7
New cards

Proton pump inhibitors (PPIs) block:

Both basal and stimulated secretion

8
New cards

Which statement correctly describes the action of the gastric proton pump (H⁺/K⁺-ATPase)?

Pumps hydrogen ions into the stomach → increases proton concentration → decreases pH

9
New cards

Which statement best explains why proton pump inhibitors (PPIs) are more effective than H2-receptor antagonists in reducing gastric acid secretion?

H2 antagonists block stimulated gastric acid secretion, but PPIs inhibit the proton pump itself, blocking both basal and stimulated secretion.

10
New cards
<p><strong>Which statement best explains why older methods (e.g., atropine, proglumide, H₂ antagonists) are less effective than PPIs for reducing gastric acid?</strong> </p>

Which statement best explains why older methods (e.g., atropine, proglumide, H₂ antagonists) are less effective than PPIs for reducing gastric acid?

They block only upstream stimulatory pathways (ACh, gastrin, histamine) and do not block the proton pump itself

11
New cards

The drug becomes acidic → increases solubility and dissolution

12
New cards

What happens if a PPI is formulated with HCl?

The drug becomes basic

13
New cards

Proton pump inhibitors are best described as:

Prodrugs activated in acidic environments

14
New cards

Where do PPIs become activated?

Secretory canaliculus of parietal cells

15
New cards

PPIs react with which functional group on the proton pump?

Thiol group

16
New cards

At neutral pH PPIs are:

Inactive, chemically stable, lipid-soluble, weak bases

17
New cards

How do PPIs reach the parietal cells?

From the bloodstream

18
New cards

Why do PPIs accumulate in the secretory canaliculi?

They become protonated and trapped

19
New cards

Parietal cell canaliculi are unique because they:

Have the lowest pH in the body

20
New cards

Once protonated, PPIs convert to:

Sulfenamide and sulfenic acid

21
New cards

PPIs bind to the pump by:

Covalent bond formation

22
New cards

PPIs convert to their active form fastest at:

Very low pH (acidic environment)

23
New cards

Why do PPIs require enteric coating?

To prevent premature activation in the acidic stomach

24
New cards

Where are PPIs absorbed after oral administration?

Small intestines

25
New cards

What happens as pH increases?

Conversion rate decreases

26
New cards

Why must PPIs avoid activation in the stomach?

They would be trapped and not reach parietal cells

27
New cards

Most drug absorption occurs in intestines because:

Larger surface area

28
New cards

PPIs irreversibly inhibit the H⁺/K⁺-ATPase by:

Covalently reacting with thiol groups on cysteine residues of the pump

29
New cards

At least ______ molecules of the PPI sulfenamide form must react with thiol groups on the H⁺/K⁺-ATPase to fully inhibit the pump.

two

30
New cards

Which cysteine residue is a key target on the H⁺/K⁺-ATPase for covalent binding by PPIs?

Cys-813

31
New cards

PPI specificity is primarily derived from:

Requirement for acidic conditions and trapping in the canaliculus

32
New cards

Trapping of the protonated PPI occurs in the:

Acidic secretory canaliculus adjacent to the enzyme

33
New cards

Omeprazole administration results in:

Permanent inhibition of H⁺/K⁺-ATPase in vivo

34
New cards

Acid secretion resumes only when:

New H⁺/K⁺-ATPase pumps are synthesized and inserted in the membrane

35
New cards

PPIs are formulated as:

Enteric-coated microcapsules or granules

36
New cards

Why are PPIs enteric-coated?

To prevent activation in the mouth and stomach

37
New cards

What happens if the enteric coating is disrupted in the mouth before swallowing?

Neutral pH releases drug prematurely

38
New cards

Premature release in the mouth or esophagus leads to:

Cyclization in the stomach lumen and drug inactivation

39
New cards

In which GI region do PPIs normally dissolve and absorb due to pH?

Duodenum (pH ~6.8)

40
New cards

Which statement best describes esomeprazole?

S-enantiomer of omeprazole

41
New cards

Phase I metabolism of PPIs typically includes:

O-dealkylation and sulfone formation

42
New cards

Phase II metabolism of PPIs primarily involves:

Glucuronidation

43
New cards

OTC PPIs like omeprazole should be used for a maximum of:

14 days

44
New cards

Why is long-term PPI use avoided without supervision?

Raises stomach pH, increasing infection risk

45
New cards

PPIs MOA

  1. PPIs are prodrugs

    • Inactive at neutral pH

    • Lipid-soluble, weak bases → can cross membranes

  2. Absorbed into the bloodstream and delivered to parietal cells

  3. Diffuse into the secretory canaliculi

    • Only location in body with very low pH

  4. Become protonated (acidic environment)

    • Acid activates them and causes them to become trapped in the canaliculus

  5. Chemical rearrangement

    • Protonated parent drug → forms sulfenic acid and sulfenamide

  6. Covalent binding

    • Sulfenamide reacts with thiol (–SH) groups on H⁺/K⁺-ATPase

    • Forms covalent disulfide bond

  7. Permanent enzyme inactivation

    • Pump is irreversibly inhibited

    • Acid secretion stops

  8. Recovery only when new pumps are made

    • Parietal cell must synthesize and insert new pumps into membrane

    • (Hence long duration despite short half-life in plasma)